These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32207675)

  • 21. Cardiovascular health and rate of cognitive decline in preclinical dementia: A 12-year population-based study.
    Speh A; Payton NM; Kramberger MG; Grande G; Qiu C; Winblad B; Fratiglioni L; Bäckman L; Laukka EJ
    Neuropsychology; 2024 Mar; 38(3):211-222. PubMed ID: 38330362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
    Eckerström C; Olsson E; Klasson N; Berge J; Nordlund A; Bjerke M; Wallin A
    J Alzheimers Dis; 2015; 44(1):205-14. PubMed ID: 25201779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive, Genetic, Brain Volume, and Diffusion Tensor Imaging Markers as Early Indicators of Dementia.
    Müller T; Payton NM; Kalpouzos G; Jessen F; Grande G; Bäckman L; Laukka EJ
    J Alzheimers Dis; 2020; 77(4):1443-1453. PubMed ID: 32925047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.
    Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D;
    J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple cognitive deficits during the transition to Alzheimer's disease.
    Bäckman L; Jones S; Berger AK; Laukka EJ; Small BJ
    J Intern Med; 2004 Sep; 256(3):195-204. PubMed ID: 15324363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
    Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
    Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
    Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors That a Diagnosis of Mild Cognitive Impairment Will Remain Stable 3 Years Later.
    Clem MA; Holliday RP; Pandya S; Hynan LS; Lacritz LH; Woon FL
    Cogn Behav Neurol; 2017 Mar; 30(1):8-15. PubMed ID: 28323681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia.
    Grilli MD; Wank AA; Bercel JJ; Ryan L
    J Int Neuropsychol Soc; 2018 Nov; 24(10):1073-1083. PubMed ID: 30136918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    Dodich A; Cerami C; Cappa SF; Marcone A; Golzi V; Zamboni M; Giusti MC; Iannaccone S
    J Alzheimers Dis; 2018; 61(2):761-772. PubMed ID: 29254091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
    de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
    J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment.
    García-Herranz S; Díaz-Mardomingo MC; Peraita H
    J Neuropsychol; 2016 Sep; 10(2):239-55. PubMed ID: 25809316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting decline in mild cognitive impairment: a prospective cognitive study.
    Belleville S; Gauthier S; Lepage E; Kergoat MJ; Gilbert B
    Neuropsychology; 2014 Jul; 28(4):643-52. PubMed ID: 24588699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting?
    Meijs AP; Claassen JA; Rikkert MG; Schalk BW; Meulenbroek O; Kessels RP; Melis RJ
    Age Ageing; 2015 Jan; 44(1):72-7. PubMed ID: 24847028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.